Article Reviews Advances in Corneal Cross-Linking and the Importance of Early Keratoconus Treatment

In a recent article, Epion’s Senior Advisor for Professional Strategy and Relations, S. Barry Eiden, OD, FAAO, reviews the evolution of corneal cross-linking (CXL) and its role in managing keratoconus, with particular emphasis on pediatric disease. The article highlights how newer riboflavin formulations used in transepithelial (“epi-on”) cross-linking may improve safety, comfort, and visual recovery while maintaining efficacy. Drawing on clinical trial data and pediatric studies, the review underscores that keratoconus is often aggressive in younger patients and reinforces the critical importance of early diagnosis and timely intervention to preserve long-term vision.